Zofia E. Dziewanowska

Zofia E. Dziewanowska

82 year
Health Technology
Consumer Services
Commercial Services

Profile

Zofia E.
Dziewanowska
held several high-ranking positions in the pharmaceutical industry, including Vice President of Clinical Research at Ligand Pharmaceuticals and Senior Vice President of Global Clinical Research and Development at Cypros Pharmaceutical Corp.
She also served as Vice Chairman of the Medical Section Steering Committee at the Pharmaceutical Research & Manufacturers of America and Chairman of the Education Committee at the American Academy of Pharmaceutical Physicians.
Prior to her industry career, she earned doctorates from Warsaw University of Technology, the University of Warsaw, and the Polish Academy of Sciences.

Former positions of Zofia E. Dziewanowska

CompaniesPositionEnd
LIGAND PHARMACEUTICALS INCORPORATED Chief Tech/Sci/R&D Officer 2008-12-31
Cypros Pharmaceutical Corp. Chief Tech/Sci/R&D Officer 2007-09-20
MERCK & CO., INC. Chief Tech/Sci/R&D Officer 1993-12-31
American Academy of Pharmaceutical Physicians Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Zofia E. Dziewanowska's experience

Training of Zofia E. Dziewanowska

Warsaw University of Technology Doctorate Degree
University of Warsaw Doctorate Degree
Polish Academy of Sciences Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zofia E. Dziewanowska's experience

Connections

35

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MERCK & CO., INC.

Health Technology

LIGAND PHARMACEUTICALS INCORPORATED

Health Technology

Private companies6
Cypros Pharmaceutical Corp.

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

American Academy of Pharmaceutical Physicians

See company connections
  1. Stock Market
  2. Insiders
  3. Zofia E. Dziewanowska
Over 1,000,000 investors have joined us.
Thank you!
Days
Hours
Minutes
Seconds
Subscribe now
Over 1,000,000 investors have joined us.
Thank you!
Days
Hours
Minutes
Seconds
Subscribe now